BI, Lilly's diabetes drug Linagliptin shows efficacy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 Aug, 2013
Singapore: Boehringer Ingelheim and Eli Lilly's investigational Type 2 Diabetes (T2D) drug dipeptidyl peptidase-4 (DPP-4...Read more
Actavis 'pregnancy preventer' gets FDA nod
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 17 May, 2013
Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch ...Read more
Aussie firm Phosphagenics raises $11.45 mn
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2014
Singapore: Australian drug delivery company, Phosphagenics, has raised $11.45 million of its $15.29 million capital rais...Read more
Patrys gets nod to progress myeloma trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Jan, 2013
Singapore: Patrys, Australia's clinical stage biopharmaceutical company, has received approval to progress its phase I/I...Read more
Eisai seeks approval for antiepileptic agent in Japan
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 31 Aug, 2012
Singapore: Eisai has submitted a marketing authorization application to Japan's Ministry of Health, Labor and Welfare (M...Read more
Bayer progresses on APAC hepatocellular carcinoma trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2013
Singapore: GIDEON (Global Investigation of therapeutic Decisions in hepatocellular carcinoma and of its treatment with s...Read more
Cipla malaria drug gets WHO pre-qualification
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Oct, 2012
Mumbai: Cipla along with the non-profit R&D organization, Drugs for Neglected Diseases initiative (DNDi), revealed t...Read more
Boston Strategics gets rights for Eisai's cancer drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2014
Singapore: Boston Strategics Corp (BSC), a clinical-stage drug research and development (R&D) company has signed an ...Read more
Activation of mTorc1 causes colon, gastric cancers
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Jan, 2013
Singapore: Associate Professor Matthias Ernst and colleagues from Australia's Walter and Eliza Hall Institute have ident...Read more
ASLAN announces global license agreement with Almirall
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 May, 2012
Singapore: ASLAN Pharmaceuticals has obtained the global rights to Almirall's DHODH inhibitor, LAS186323, currently in p...Read more
Ian Frazer gets $200k to make HPV DNA vaccine
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Dec, 2012
Singapore: Professor Ian Frazer and his team at the University of Queensland, have been awarded grant from Australia's N...Read more
South Korea firm emerges as R&D force
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Apr, 2012
According to the Global Burden of Disease and Risk Factors (World Bank Publications, 2006), infectious diseases are one ...Read more
FDA offers guidance on Alzheimer's drug development
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Feb, 2013
Singapore: The US Food and Drug Administration has issued a proposal designed to assist companies developing new treatme...Read more
Zydus initiates Ph III trial of Lipaglyn for lipodystrophy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Jun, 2014
Singapore: India based drug company, Zydus, has initiated Phase III trials of Lipaglyn (Saroglitazar) to evaluate its sa...Read more
Australian firm gets rights to Anamorelin
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Oct, 2012
Singapore: Melbourne-based biopharmaceutical company Specialised Therapeutics Australia (STA) has been granted exclusive...Read more
3SBio acquires patents for kidney failure drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 31 Oct, 2013
Singapore: China-based 3SBio, which is focused on R&D, manufacturing and marketing biopharmaceutical products, acqu...Read more
Glenmark's MAb drug enters human trials
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Jul, 2014
Singapore: Glenmark Pharmaceuticals, a research-driven, global integrated pharmaceutical company announced that its nove...Read more
Avantor launches polysorbates for pharma
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2013
Singapore: US-based Avantor Performance Materials has introduced a higher purity Super Refined grade of polysorbate prod...Read more